|
Enanta Pharmaceuticals Inc. |
|
|
500 Arsenal Street
Watertown, MA 02472 USA
phone:(617) 607-0800
fax:(617) 607-0530 |
| Symbol |
private |
| Exchange |
|
| Founded |
0 |
| Employees |
|
|
|
| www.enanta.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Small molecule drugs to treat diseases including pneumonia. |
|
| Management |
| Jay R. Luly, Ph.D., President, Chief Executive Officer and Director; Yat Sun Or, Ph.D., Senior Vice President, Research and Development; Paul J. Mellett, Senior Vice President, Finance, Administration and Chief Financial Officer; Yujiro S. Hata, Senior Vice President, Business Development |
|
|
| |
| Keywords |
| small molecule drugs, antibiotic, pneumonia |
|
|
|
|
|
| Description |
|
Enanta Pharmaceuticals, Inc. is developing a pipeline of small molecule drugs based on the application of its chemistry and drug discovery and development capabilities. |
|
| Products / Services |
EDP-420, a Bridged Bicyclic Macrolide (BBM) antibiotic, entered Phase II clinical trials, for the treatment of community acquired pneumonia.
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members